Browsing Tag

business update

Celyad Oncology provides an update on its strategic business model, continuing to…

Eli Pacheco Dec 21, 2022 0

MONT-SAINT-GUIBERT, Belgium, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on the discovery and…

Health

ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update

Eli Pacheco Dec 2, 2022 0

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 1, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN) (“ObsEva” or the “Company”), a…

Business

GeoJunxion (GOJXN.AS) announces the booking of a series of Location Intelligence…

Dustin Moskovitz Aug 9, 2022 0

Capelle aan den IJssel, The Netherlands – 8 August 2022 – GeoJunxion (GOJXN.AS) is pleased to announce the booking of a series of Location Intelligence Service contracts with combined value…

Business

GeoJunxion (GOJXN.AS) kondigt de boeking aan van een reeks Location Intelligence…

Dustin Moskovitz Aug 9, 2022 0

Capelle aan den IJssel, The Netherlands – 8 augustus 2022 – GeoJunxion (GOJXN.AS) kondigt de boeking aan van een reeks Location Intelligence Services met een gecombineerde waarde van ruim…

Health

ObsEva to Host Conference Call and Webcast to Discuss First Quarter 2022 Financial…

Eli Pacheco May 12, 2022 0

GENEVA, Switzerland – May 12, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that…

Health

ObsEva Announces Third Quarter 2021 Financial Results and Business Update

Eli Pacheco Nov 4, 2021 0

-Linzagolix for uterine fibroids: Pending regulatory approval in the US and Europe with commercial planning efforts underway- -Linzagolix for endometriosis: Readout from Phase 3…